← Back to Search

Decision Aid Tool for Colorectal Cancer Screening

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between the ages of 75 and 85 years

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after the intervention

Awards & highlights

Study Summary

This trialwill study if a new decision aid tool can help seniors make better decisions about colorectal cancer screening. It will test if it can increase knowledge and engagement, and if it's acceptable.

Who is the study for?

This trial is for adults aged 75-85 with low health literacy, who feel somewhat to not at all confident filling out medical forms. They should have a community college education or less and no history of colorectal cancer, dementia, or lack the capacity to participate.Check my eligibility

What is being tested?

The study tests if a new decision aid pamphlet helps these older adults decide about colorectal cancer screening. It looks at their intention to get screened based on life expectancy and risk factors, knowledge increase, engagement in shared decision-making (SDM), and acceptance of the aid.See study design

What are the potential side effects?

Since this trial involves educational materials rather than medications or invasive procedures, there are no direct physical side effects expected from participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 75 and 85 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in CRC Screening Intentions

Secondary outcome measures

Change in Knowledge

Feelings of anxiety when reading the decision aid

Feelings of usefulness of the decision aid

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Home Safety PamphletExperimental Treatment1 Intervention

Stratifying by sex, 30 will be randomized to receive the home safety information at the visit.

Group II: CRC DAExperimental Treatment1 Intervention

Stratifying by sex, 30 participants will be randomized to receive the CRC DA pamphlet.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,010 Previous Clinical Trials

42,895,461 Total Patients Enrolled

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

145,584 Total Patients Enrolled

Simmons UniversityLead Sponsor

Media Library

Home Safety Pamphlet Clinical Trial Eligibility Overview. Trial Name: NCT04748380 — N/A

Colorectal Cancer Research Study Groups: Home Safety Pamphlet, CRC DA

Colorectal Cancer Clinical Trial 2023: Home Safety Pamphlet Highlights & Side Effects. Trial Name: NCT04748380 — N/A

Home Safety Pamphlet 2023 Treatment Timeline for Medical Study. Trial Name: NCT04748380 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can participants aged 40 and over take part in this clinical experiment?

"This study is welcoming participants aged between 75 and 85 years to take part."

Answered by AI

Is participation in this research endeavor open to me?

"To meet the eligibility requirements for this clinical trial, candidates must have colorectal cancer and be between 75 to 85 years of age. Approximately 60 participants are needed for recruitment purposes."

Answered by AI

Are there vacancies available for participants in this examination?

"Affirmative, the data on clinicaltrials.gov highlights that this investigation is actively accepting patients. It was initially posted in December 16th 2022 and augmented on January 13th 2023. The target of 60 participants should be enrolled from 1 center."

Answered by AI

What is the aggregate size of the participants in this clinical trial?

"Affirmative. Clinicaltrials.gov has the most current information on this clinical trial which launched in December 2022 and was revised January of 2023. The study is seeking 60 individuals from a single location for enrollment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Shared Decision-making and Colorectal Cancer Screening

Tamara J. Cadet, PhD, LICSW, MPH 2023. "Shared Decision-making and Colorectal Cancer Screening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04748380.

All > Colorectal Cancer Baltimore